Table Of Content
Table of Content
1 Industrial Chain Overview
1.1 Drugs for Non-small Cell Lung Cancer Industry
1.1.1 Overview
Figure Drugs for Non-small Cell Lung Cancer Picture List
1.1.2 Characteristics of Drugs for Non-small Cell Lung Cancer
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Radiofrequency Ablation (RFA)
1.3.2 Radiation Therapy
1.3.3 Chemotherapy
1.3.4 Targeted Therapies
1.3.5 Immunotherapy
1.4 End-Use List
1.4.1 Demand in Hospital
1.4.2 Demand in Clinic
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2016-2026
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
3.2 Manufacturers List
3.2.1 Bristol-Myers Squibb Overview
Table Bristol-Myers Squibb Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 GlaxoSmithKline Overview
Table GlaxoSmithKline Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Menarini Overview
Table Menarini Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Sanofi Overview
Table Sanofi Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Ziopharm Oncology Overview
Table Ziopharm Oncology Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Alchemia Overview
Table Alchemia Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Amgen Overview
Table Amgen Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Apotex Overview
Table Apotex Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 BioMarin Pharmaceutical Overview
Table BioMarin Pharmaceutical Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 CellAct Pharma Overview
Table CellAct Pharma Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Cerulean Pharma Overview
Table Cerulean Pharma Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Cipla Overview
Table Cipla Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Cornerstone Pharmaceuticals Overview
Table Cornerstone Pharmaceuticals Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Curis Overview
Table Curis Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 CytRx Overview
Table CytRx Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Eli Lilly Overview
Table Eli Lilly Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Exelixis Overview
Table Exelixis Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Fresenius Kabi Overview
Table Fresenius Kabi Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Genentech Overview
Table Genentech Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 Hikma Pharmaceuticals Overview
Table Hikma Pharmaceuticals Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Hospira Overview
Table Hospira Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Intas Pharmaceuticals Overview
Table Intas Pharmaceuticals Overview List
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
3.2.23 Karyopharm Therapeutics Overview
Table Karyopharm Therapeutics Overview List
3.2.23.1 Product Specifications
3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.23.3 Recent Developments
3.2.23.4 Future Strategic Planning
3.2.24 Kyowa Hakko Kirin Overview
Table Kyowa Hakko Kirin Overview List
3.2.24.1 Product Specifications
3.2.24.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.24.3 Recent Developments
3.2.24.4 Future Strategic Planning
3.2.25 Ligand Pharmaceuticals Overview
Table Ligand Pharmaceuticals Overview List
3.2.25.1 Product Specifications
3.2.25.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.25.3 Recent Developments
3.2.25.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Radiofrequency Ablation (RFA)
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA) , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA) , 2016-2020, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Radiation Therapy
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Radiation Therapy , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Radiation Therapy , 2016-2020, in Volume
5.2.2.2 Situation & Development
5.2.3 Market in Chemotherapy
5.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Chemotherapy , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Chemotherapy , 2016-2020, in Volume
5.2.3.2 Situation & Development
5.2.4 Market in Targeted Therapies
5.2.4.1 Market Size
Figure Global Market Amount and Growth Rate in Targeted Therapies , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Targeted Therapies , 2016-2020, in Volume
5.2.4.2 Situation & Development
5.2.5 Market in Immunotherapy
5.2.5.1 Market Size
Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in Volume
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
6.2 Segment Subdivision
6.2.1 Market in Hospital
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Hospital , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Hospital , 2016-2020, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Clinic
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Clinic , 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Clinic , 2016-2020, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Drugs for Non-small Cell Lung Cancer Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion
Tables & Figures
List of Tables as follows:
List of Table
Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026
Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026
Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026
Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume
Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Bristol-Myers Squibb Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Menarini Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ziopharm Oncology Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Alchemia Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Amgen Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Apotex Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table BioMarin Pharmaceutical Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table CellAct Pharma Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cerulean Pharma Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cipla Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Cornerstone Pharmaceuticals Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Curis Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table CytRx Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Exelixis Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Fresenius Kabi Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Genentech Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Hikma Pharmaceuticals Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Hospira Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Karyopharm Therapeutics Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Ligand Pharmaceuticals Overview List
Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2016-2020, in Volume
Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume
Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD
Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume
Table Global Market Forecast by Region Segment 2021-2026, in Million USD
Table Global Market Forecast by Region Segment 2021-2026, in Volume
Table Global Market Amount by Product Type Segment 2021-2026, in Million USD
Table Global Market Volume by Product Type Segment 2021-2026, in Volume
Table Global Market Amount by End-Use Segment 2021-2026, in Million USD
Table Global Market Volume by End-Use Segment 2021-2026, in Volume
List of Figures as follows:
List of Figure
Figure Drugs for Non-small Cell Lung Cancer Picture List
Figure Global Market Size and Forecast with Growth Rate, 2016-2026
Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Global Market Volume and Growth Rate, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD
Figure North America Market Volume and Growth Rate, 2016-2020, in Volume
Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD
Figure South America Market Volume and Growth Rate, 2016-2020, in Volume
Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD
Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume
Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD
Figure Global Market Size and Growth Rate, 2016-2020, in Volume
Figure Global Market Size and Growth Rate, 2016-2020, in Million USD
Figure Global Competition Sketch Overview
Figure Global Production Volume Share by Manufacturers in 2020, in Volume
Figure Global Production Amount Share by Manufacturers in 2020, in Million USD
Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA), 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Radiofrequency Ablation (RFA), 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Radiation Therapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Radiation Therapy, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Chemotherapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Chemotherapy, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Targeted Therapies, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Targeted Therapies, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Immunotherapy, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Hospital, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Hospital, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Clinic, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Clinic, 2016-2020, in Volume
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume
Figure Cost Component Ratio
